| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Science/ Medical Officer
1 company
Strayer David R serves as a Chief Science/ Medical Officer at AIM. Across recent SEC filings that breaks down to 3 buys and 0 sells. Those positions are worth an estimated $22K at current prices.
The biggest single holding is AIM (~$22K) as Chief Science/ Medical Officer. Net of sales, the recent Form 4 record there shows accumulation of 20,310 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2019 | AIM Aim Immunotech Inc. | Chief Science/ Medical Officer | Buy | 2,481 | $4.03 | $9,998.43 | +84.4% | |
| May 2, 2017 | AIM Aim Immunotech Inc. | Chief Science/ Medical Officer | Buy | 7,937 | $0.63 | $5,000.31 | +23.4% | |
| Feb 16, 2017 | AIM Aim Immunotech Inc. | Chief Science/ Medical Officer | Buy | 9,892 | $0.46 | $4,550.32 | +41.3% |